Who owns CorMedix Inc. (CRMD)? Elite investor 13F holders

2 tracked elite investors reported holding CorMedix Inc as of 2026-09-30, including D.E. Shaw, Renaissance Technologies LLC. Who bought, trimmed or exited each quarter, with links to the original SEC 13F filings.

2 tracked investors currently reported holding · Latest report period: 2026-09-30 · Health Care · Pharmaceuticals, Biotechnology & Life Sciences

CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for life-threatening diseases and conditions in the United States. Its lead product candidate is DefenCath, an antimicrobial catheter lock solution to reduce the incidence of catheter-related bloodstream infections in adult patients with kidney failure. CorMedix Inc. was formerly known as…

Reported holders and securities, including exits (up to 20)

Reported holders and securities, including exits (up to 20)
InvestorSecurityInstrumentReport periodFiledValueQuantityUnitsChangeSource
D.E. ShawCORMEDIX INCSHARE2026-09-302026-11-16 00:00:002544604.00 USD330468.000000SharesaddOriginal filing
Renaissance Technologies LLCCORMEDIX INCSHARE2026-09-302026-11-12 00:00:00420243.00 USD54577.000000SharesbuyOriginal filing
Gotham Asset ManagementCORMEDIX INCSHARE2026-09-302026-11-16 00:00:000.00 USD0.000000SharesexitedOriginal filing

Public disclosures can be delayed, incomplete, or amended. Report period describes a position date; transaction date describes a reported transaction; filed describes submission. A recent filing or page update does not establish a current holding. A dash means unavailable or not comparable, not zero.

This public summary shows the default reporting scope. Enable JavaScript for interactive filters, charts, and additional rows.

How to read the data · Disclaimer

Read as Markdown